The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP targets for the periods indicated below.
GAAP to Non-GAAP Reconciliation of First Quarter Fiscal Year 2025 Targets | ||
(in thousands, except per share amounts) | ||
|
|
|
|
|
|
| |
|
| Range for Three Months Ending | |
|
| January 31, 2025 | |
|
| Low | High |
Target GAAP expenses | $ 1,142,000 | $ 1,162,000 |
Adjustments: |
|
|
Amortization of acquired intangible assets | (12,000) | (15,000) |
Stock-based compensation | (185,000) | (192,000) |
Target non-GAAP expenses | $ 945,000 | $ 955,000 |
|
|
|
|
|
|
|
|
|
|
| |
|
| Range for Three Months Ending | |
|
| January 31, 2025 | |
|
| Low | High |
Target GAAP earnings per diluted share attributed to Synopsys | $ 1.81 | $ 1.95 |
Adjustments: |
|
|
Amortization of acquired intangible assets | 0.10 | 0.08 |
Stock-based compensation | 1.22 | 1.18 |
Acquisition/divestiture related items (1) | 0.08 | 0.06 |
Tax adjustments | (0.44) | (0.45) |
Target non-GAAP earnings per diluted share attributed to Synopsys | $ 2.77 | $ 2.82 |
|
|
|
|
Shares used in non-GAAP calculation (midpoint of target range) | 157,000 | 157,000 |
|
|
|
|
|
|
|
|
GAAP to Non-GAAP Reconciliation of Full Fiscal Year 2025 Targets | ||
(in thousands, except per share amounts) | ||
|
|
|
|
|
|
| |
|
| Range for Fiscal Year Ending | |
|
| October 31, 2025 | |
|
| Low | High |
Target GAAP expenses | $ 4,926,000 | $ 4,983,000 |
Adjustments: |
|
|
Amortization of acquired intangible assets | (46,000) | (51,000) |
Stock-based compensation | (835,000) | (847,000) |
Target non-GAAP expenses | $ 4,045,000 | $ 4,085,000 |
|
|
|
|
|
|
|
|
|
|
| |
|
| Range for Fiscal Year Ending | |
|
| October 31, 2025 | |
|
| Low | High |
| Target GAAP earnings per diluted share attributed to Synopsys | $ 10.42 | $ 10.63 |
| Adjustments: |
|
|
| Amortization of acquired intangible assets | 0.32 | 0.29 |
| Stock-based compensation | 5.36 | 5.28 |
| Acquisition/divestiture related items (1) | 0.29 | 0.26 |
| Tax adjustments | (1.51) | (1.50) |
| Target non-GAAP earnings per diluted share attributed to Synopsys | $ 14.88 | $ 14.96 |
|
|
|
|
| Shares used in non-GAAP calculation (midpoint of target range) | 158,000 | 158,000 |
|
|
|
|
| (1) Adjustments reflect certain contractually obligated financing fees and related amortization expenses, and do not fully reflect all potential adjustments for future periods for the reasons set forth in "GAAP to Non-GAAP Reconciliation" below. | ||
